Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.27 USD | -0.95% | +16.69% | +44.82% |
06-20 | Sector Update: Health Care Stocks Mixed Thursday Afternoon | MT |
06-20 | ImmunityBio Shares Rise After Launch of Bladder Cancer Treatment Anktiva in US | MT |
Evolution of the average Target Price on ImmunityBio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering ImmunityBio, Inc.
Piper Sandler | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- IBRX Stock
- Consensus ImmunityBio, Inc.